title: Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.
authors.affiliation: Division of Cardiology, University Hospitals of Cleveland, Ohio 44106.
authors.forename: E M
authors.initials: EM
authors.lastname: Bednarczyk
authors.forename: W B
authors.initials: WB
authors.lastname: White
authors.forename: M A
authors.initials: MA
authors.lastname: Munger
authors.forename: F M
authors.initials: FM
authors.lastname: Gonzalez
authors.forename: E A
authors.initials: EA
authors.lastname: Panacek
authors.forename: S G
authors.initials: SG
authors.lastname: Weed
authors.forename: W F
authors.initials: WF
authors.lastname: Rutherford
authors.forename: A R
authors.initials: AR
authors.lastname: Nara
authors.forename: J A
authors.initials: JA
authors.lastname: Green
mesh_terms: D000328:Adult; D000368:Aged; D001552:Benzazepines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D018818:Fenoldopam; D005292:Ferricyanides / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001552:Benzazepines; D005292:Ferricyanides; D014665:Vasodilator Agents; D009599:Nitroprusside; D018818:Fenoldopam